3.84
price up icon5.79%   0.21
 
loading
전일 마감가:
$3.63
열려 있는:
$3.61
하루 거래량:
6.33M
Relative Volume:
0.94
시가총액:
$356.07M
수익:
-
순이익/손실:
$-69.31M
주가수익비율:
-3.0236
EPS:
-1.27
순현금흐름:
$-62.80M
1주 성능:
+23.08%
1개월 성능:
+54.84%
6개월 성능:
-40.65%
1년 성능:
-20.17%
1일 변동 폭
Value
$3.58
$4.09
1주일 범위
Value
$2.9537
$4.09
52주 변동 폭
Value
$1.07
$11.46

Rezolute Inc Stock (RZLT) Company Profile

Name
명칭
Rezolute Inc
Name
전화
650-206-4507
Name
주소
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Name
직원
71
Name
트위터
Name
다음 수익 날짜
2025-09-17
Name
최신 SEC 제출 서류
Name
RZLT's Discussions on Twitter

Compare RZLT vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RZLT
Rezolute Inc
3.84 336.60M 0 -69.31M -62.80M -1.27
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
491.47 117.98B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
803.17 82.85B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
821.96 51.58B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
314.40 40.75B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
346.07 38.33B 4.98B 69.60M 525.67M 0.5198

Rezolute Inc Stock (RZLT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-12-11 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2025-12-11 다운그레이드 Craig Hallum Buy → Hold
2025-12-11 다운그레이드 Wedbush Outperform → Neutral
2024-11-05 개시 Wedbush Outperform
2024-08-27 개시 Guggenheim Buy
2024-07-17 개시 BTIG Research Buy
2024-06-04 개시 Craig Hallum Buy
2024-04-09 개시 Maxim Group Buy
2022-08-02 재개 Canaccord Genuity Buy
2022-06-15 개시 Cantor Fitzgerald Overweight
2021-09-08 개시 ROTH Capital Buy
2021-05-27 개시 Oppenheimer Outperform
2021-05-25 개시 H.C. Wainwright Buy
모두보기

Rezolute Inc 주식(RZLT)의 최신 뉴스

pulisher
12:31 PM

Biotech Company Advances Breakthrough Hyperinsulinism Treatment - streetwisereports.com

12:31 PM
pulisher
Feb 13, 2026

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - PR Newswire

Feb 13, 2026
pulisher
Feb 12, 2026

Is Rezolute Inc. a top pick in the sectorWeekly Investment Recap & High Return Stock Watch Alerts - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Is Rezolute Inc. benefiting from interest rate changesWeekly Trade Summary & Long-Term Safe Investment Ideas - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Rezolute (NASDAQ:RZLT) Announces Quarterly Earnings Results - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Rezolute (RZLT) Reports Decline in Cash Reserves by Year-End - GuruFocus

Feb 12, 2026
pulisher
Feb 12, 2026

Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - The Manila Times

Feb 12, 2026
pulisher
Feb 12, 2026

Press Release: Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - 富途牛牛

Feb 12, 2026
pulisher
Feb 11, 2026

Will Rezolute Inc. benefit from rate cutsPortfolio Return Summary & Step-by-Step Trade Execution Guides - mfd.ru

Feb 11, 2026
pulisher
Feb 11, 2026

Is Rezolute Inc. backed by strong institutional buyingTrade Exit Report & Short-Term Swing Trade Alerts - mfd.ru

Feb 11, 2026
pulisher
Feb 09, 2026

Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - GlobeNewswire

Feb 09, 2026
pulisher
Feb 09, 2026

Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - GlobeNewswire Inc.

Feb 09, 2026
pulisher
Feb 09, 2026

Can Rezolute Inc. stock hit record highs againWeekly Trend Recap & Weekly High Potential Stock Alerts - mfd.ru

Feb 09, 2026
pulisher
Feb 07, 2026

Faruqi & Faruqi Investigates Losses in Rezolute Stock - Intellectia AI

Feb 07, 2026
pulisher
Feb 06, 2026

Surprises Report: Is Rezolute Inc stock trending bullishJuly 2025 Recap & Community Verified Swing Trade Signals - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 05, 2026

SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - marketscreener.com

Feb 05, 2026
pulisher
Feb 04, 2026

Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times

Feb 04, 2026
pulisher
Feb 04, 2026

Rezolute, Inc. to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 - Quiver Quantitative

Feb 04, 2026
pulisher
Feb 04, 2026

Rezolute (RZLT) Projected to Post Earnings on Wednesday - MarketBeat

Feb 04, 2026
pulisher
Feb 03, 2026

SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investig - The National Law Review

Feb 03, 2026
pulisher
Feb 03, 2026

Profit Recap: Should I hold or sell Lumen Technologies Inc nowForecast Cut & Proven Capital Preservation Methods - baoquankhu1.vn

Feb 03, 2026
pulisher
Feb 03, 2026

Rezolute’s Phase 3 SunRIZE study for Ersodetug fails to meet primary and secondary endpoints despite analyst backing - MSN

Feb 03, 2026
pulisher
Feb 01, 2026

Rezolute, Inc. (NASDAQ:RZLT) Sees Significant Increase in Short Interest - MarketBeat

Feb 01, 2026
pulisher
Jan 31, 2026

Rezolute, Inc. (NASDAQ:RZLT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Jan 31, 2026
pulisher
Jan 30, 2026

Rezolute (NASDAQ:RZLT) Shares Down 3.8%What's Next? - MarketBeat

Jan 30, 2026
pulisher
Jan 27, 2026

Faruqi & Faruqi Encourages Rezolute Investors to Discuss Legal Options - intellectia.ai

Jan 27, 2026
pulisher
Jan 26, 2026

Analysis Recap: Will Rezolute Inc benefit from rate cutsJuly 2025 Volume & Low Volatility Stock Recommendations - baoquankhu1.vn

Jan 26, 2026
pulisher
Jan 25, 2026

Rezolute shares in focus after RA Capital discloses 9.9% stake - MSN

Jan 25, 2026
pulisher
Jan 25, 2026

INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus

Jan 25, 2026
pulisher
Jan 25, 2026

INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - Prime Publishers, Inc.

Jan 25, 2026
pulisher
Jan 23, 2026

RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - Chartmill

Jan 23, 2026
pulisher
Jan 22, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc.RZLT - PR Newswire

Jan 22, 2026
pulisher
Jan 21, 2026

Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - marketscreener.com

Jan 21, 2026
pulisher
Jan 20, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - GlobeNewswire Inc.

Jan 20, 2026
pulisher
Jan 18, 2026

Trading Recap: Is Rezolute Inc a top pick in the sectorPortfolio Gains Summary & Safe Swing Trade Setups - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 17, 2026

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - The Malaysian Reserve

Jan 17, 2026
pulisher
Jan 17, 2026

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus

Jan 17, 2026
pulisher
Jan 16, 2026

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - TMX Newsfile

Jan 16, 2026
pulisher
Jan 14, 2026

FMR LLC Significantly Reduces Holdings in Rezolute Inc. - GuruFocus

Jan 14, 2026
pulisher
Jan 14, 2026

Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Fail - GuruFocus

Jan 14, 2026
pulisher
Jan 14, 2026

Entry Recap: Is Rezolute Inc a top pick in the sectorMarket Activity Summary & Precise Swing Trade Alerts - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 14, 2026

RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - GlobeNewswire

Jan 14, 2026
pulisher
Jan 14, 2026

RZLT ALERT: Levi & Korsinsky Investigates Rezolute, Inc. for Possible Securities Fraud Violations - marketscreener.com

Jan 14, 2026

Rezolute Inc (RZLT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Rezolute Inc 주식 (RZLT) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
ROBERTS BRIAN KENNETH
Chief Medical Officer
Dec 16 '25
Buy
1.70
28,000
47,600
308,352
Evans Daron
CFO
Dec 15 '25
Buy
1.77
40,000
70,640
415,900
Evans Daron
CFO
Dec 15 '25
Buy
1.79
5,000
8,938
7,000
Elam Nevan C
CEO
Dec 15 '25
Buy
1.59
32,000
50,880
641,119
Karnawat Sunil Ratilal
Chief Commercial Officer
Dec 15 '25
Buy
1.62
12,100
19,599
71,542
ROBERTS BRIAN KENNETH
Chief Medical Officer
Jun 25 '25
Buy
4.38
2,500
10,939
15,500
Evans Daron
CFO
Jun 24 '25
Buy
4.05
5,000
20,250
268,900
Kim Young-Jin
Director
Jun 13 '25
Buy
3.25
1,230,769
3,999,999
8,423,386
KREHER NERISSA
Director
Jun 13 '25
Buy
3.25
3,076
9,997
37,576
Hogenhuis Wladimir
Director
Mar 31 '25
Buy
2.92
6,758
19,733
84,025
$26.45
price down icon 1.12%
$45.19
price up icon 0.87%
$101.10
price up icon 0.35%
$105.87
price up icon 0.10%
$148.75
price up icon 1.77%
biotechnology ONC
$346.07
price down icon 0.10%
자본화:     |  볼륨(24시간):